海马中胆固醇神经刺激对胆固醇活动的直接增强效应
Yuta Madokoro1, Daisuke Kato1, Yo Tsuda1
1Department of Neurology, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.
hippocampal cholinergic neurostimulating peptide (HCNP) 的使用在小鼠中挽救了胆固醇功能障碍. 这种可能为阿尔茨海默氏症等神经系统疾病提供治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 介面隔膜核到海马胆固醇通路对于学习和记忆至关重要.
- 胆固醇功能障碍与阿尔茨海默氏症等神经系统疾病有关.
- 海马胆固醇神经刺激前体蛋白 (HCNP-pp) 条件淘汰 (cKO) 小鼠表现出胆固醇缺陷.
研究的目的:
- 研究化学合成的HCNP在HCNP-ppcKO小鼠胆功能障碍中的潜在救援功能.
- 评估HCNP对胆固醇轴突体积和海马体电生理学的影响.
- 探索HCNP和神经生长因子 (NGF) 信号通路之间的关系.
主要方法:
- 在HCNP-ppcKO和对照小鼠中连续两周内脑内管内注射HCNP或载体.
- 在原层中对胆固醇轴突体积的免疫组织化学分析.
- 在CA1地区对局部现场潜力的电生理学评估.
- 胆乙转移酶 (ChAT),TrkA和p75NTR在被HCNP治疗的野生类型小鼠中的量化.
主要成果:
- 在cKO和对照小鼠中,HCNP的使用显著增加了胆固醇轴突体积和乙太功率.
- 在野生型小鼠中,HCNP治疗导致TrkA和p75NTR水平显著下降.
- 这些发现表明,HCNP可以补偿降低的胆功能.
结论:
- 外在的HCNP给药可以改善胆固醇缺陷,并改善海马体功能在HCNP-pp cKO小鼠.
- 在胆固醇系统中,HCNP可能与NGF互补作用.
- 作为神经退行性疾病的治疗候选人,HCNP显示出有前途的前景,其特点是胆功能障碍.
更多相关视频
09:51Recording Synaptic Plasticity in Acute Hippocampal Slices Maintained in a Small-volume Recycling-, Perfusion-, and Submersion-type Chamber System
Published on: January 1, 2018
06:40Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry CIS-FSCV to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine
Published on: April 23, 2020
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Direct-Acting Cholinergic Agonists: Pharmacological Actions
